| Employment status and health related quality of life among Hodgkin-lymphoma survivors’–results based on data from a major treatment center in Hungary F Magyari, K Kósa, R Berecz, A Illés, Z Miltényi, Z Simon, Á Illés Health and quality of life outcomes 15, 1-9, 2017 | 29 | 2017 |
| Quality of life and fatigue in Hodgkin's lymphoma patients Z Miltényi, F Magyari, Z Simon, Á Illés Tumori Journal 96 (4), 594-600, 2010 | 21 | 2010 |
| Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies F Magyari, LI Pinczés, E Páyer, K Farkas, S Ujfalusi, Á Diószegi, M Sik, ... Annals of hematology 101 (10), 2337-2345, 2022 | 20 | 2022 |
| Malignant lymphomas and autoimmunity—a single center experience from Hungary L Váróczy, E Páyer, Z Kádár, L Gergely, Z Miltényi, F Magyari, P Szodoray, ... Clinical rheumatology 31, 219-224, 2012 | 19 | 2012 |
| Combined prognostic value of absolute lymphocyte/monocyte ratio in peripheral blood and interim PET/CT results in Hodgkin lymphoma Z Simon, S Barna, Z Miltenyi, K Husi, F Magyari, A Jona, I Garai, Z Nagy, ... International journal of hematology 103, 63-69, 2016 | 18 | 2016 |
| Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry F Marchesi, J Salmanton-García, C Buquicchio, F Itri, C Besson, ... Journal of Hematology & Oncology 16 (1), 32, 2023 | 15 | 2023 |
| Successful administration of rituximab–bendamustine regimen in the relapse of Hodgkin lymphoma after autologous hemopoietic stem cell transplantation F Magyari, Z Simon, S Barna, M Udvardy, L Váróczy, Á Illés Hematological Oncology 30 (2), 98-100, 2012 | 14 | 2012 |
| Interim PET/CT in diffuse large B-cell lymphoma may facilitate identification of good-prognosis patients among IPI-stratified patients R Nyilas, B Farkas, RR Bicsko, F Magyari, LI Pinczes, A Illes, L Gergely International Journal of Hematology 110, 331-339, 2019 | 13 | 2019 |
| Prognostic value of interim and restaging PET/CT in Hodgkin lymphoma. Results of the CHEAP (chemotherapy effectiveness assessment by PET/CT) study—long term observation Z Miltenyi, S Barna, I Garai, Z Simon, A Jona, F Magyari, M Gergely, ... Neoplasma 62 (4), 627-634, 2015 | 8 | 2015 |
| Assessment of cognitive function in long-term Hodgkin lymphoma survivors, results based on data from a major treatment center in Hungary F Magyari, I Virga, Z Simon, Z Miltényi, A Illés, K Kósa, T Ivánka, R Berecz, ... Supportive Care in Cancer 30 (6), 5249-5258, 2022 | 4 | 2022 |
| Administration of daratumumab in the case of severe pure red cell aplasia after allogeneic transplantation RR Bicsko, F Magyari, R Szasz, A Illes, L Gergely Ann Hematol Oncol 8 (2), 1331, 2021 | 4 | 2021 |
| How the epidemiology of Hodgkin lymphoma changed in Debrecen, Hungary L Pinczés, Z Miltényi, Á Jóna, F Magyari, Á Illés Medical Research Archives 4 (6), 2016 | 4 | 2016 |
| Histopathological difficulties in an adolescent lymphoma patient F Magyari, S Barna, Z Miltényi, H Rajnai, J Csomor, M Udvardy, Á Illés, ... Pathology & Oncology Research 21, 213-217, 2015 | 4 | 2015 |
| Immunological changes in diffuse large B-cell lymphomas after Rituximab-CHOP treatment: Own data and review of the literature Z Simon, Á Illés, Z Miltényi, F Magyari, L Váróczy, N Péter, L Gergely Orvosi Hetilap 153 (42), 1658-1666, 2012 | 3 | 2012 |
| Diagnostic and Therapeutic Difficulties in Diffuse Large B-cell Lymphoma Arising From HHV8 Positive Castleman Disease E Payer, Z Miltenyi, Z Simon, F Magyari, S Barna, G Mehes, A Illes Journal of Hematology 1 (2-3), 65-69, 2012 | 3 | 2012 |
| Dexamethasone Treatment for COVID-19 is Related with Increased Mortality in Haematological Malignancy Patients: Results from the EPICOVIDEHA Registry TF Aiello, J Salmanton-Garcia, F Marchesi, B Weinbergerova, A Glenthoj, ... | 2 | 2023 |
| Differential diagnostic and treatment difficulties in a patient with acquired von Willebrand syndrome F Magyari, B Kracskó, J Bedekovics, Z Bereczky, Á Illés, ... Hematology 26 (1), 301-304, 2021 | 2 | 2021 |
| Treatment of relapsed Hodgkin lymphoma after autologous stem cell Transplantation Á Illés, Z Simon, M Udvardy, F Magyari, Á Jóna, Z Miltényi Orvosi Hetilap 158 (34), 1338-1345, 2017 | 2 | 2017 |
| Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022 J Salmanton-García, F Marchesi, F Farina, B Weinbergerová, F Itri, ... EClinicalMedicine 71, 2024 | 1 | 2024 |
| Ritka lokalizációjú plasmocytoma autológ hemopoetikus őssejtátültetést követően I Virga, E Páyer, S Barna, J Bedekovics, L Váróczy, B Virga, Z Nagy, ... Hematológia–Transzfuziológia 56 (2), 93-98, 2023 | 1 | 2023 |
Dr. Miltényi ZsófiaDE ÁOK Belgyógyászati IntézetE-mail megerősítve itt: belklinika.com
